Andrew T. Kaplan
Director at Kailera Therapeutics, Inc. (KLRA)
Purchase track record
Not enough history. Based on 1 purchase with a full 90 days of price history.
—
Avg. 90-day return-27.2%
vs. S&P 500-32.2%
Beat the market0%
Paper profit on buys−$36.9M
Total bought / sold$134M / $0
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Apr 20SEC | KLRAKailera Therapeutics, Inc. | Buy | 8,398,43826,255,581 held (+47%) | $16.00 | $134M | -27.4% |
- Buy
Director Andrew T. Kaplan bought $134M of KLRA at $16.00 — first open-market purchase in our records; raises the stake by 47%.